Low Seroconversion after One Dose of AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine in Solid-Organ Transplant Recipients
BACKGROUND: Immunocompromised individuals are more susceptible to complications produced by influenza infection. As a result, solid-organ transplant (SOT) recipients were targeted as a priority group to receive AS03-adjuvanted H1N1 influenza vaccine during 2009.
Saved in:
Main Authors: | Mariangela R Resende, Shahid Husain, Jonathan Gubbay, Lianne Singer, Edward Cole, Eberhard L Renner, Coleman Rotstein |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2013/256756 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Guillain-Barré Syndrome with Fatal Outcome during HIV-1-Seroconversion: A Case Report
by: Emanuele Pontali, et al.
Published: (2011-01-01) -
Seroprevalence and Seroconversion of Dengue and Implications for Clinical Diagnosis in Amazonian Children
by: Antonio Camargo Martins, et al.
Published: (2014-01-01) -
Adjuvant Ciprofloxacin for Persistent BK Polyomavirus Infection in Kidney Transplant Recipients
by: David Arroyo, et al.
Published: (2014-01-01) -
Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma
by: Kirti Shetty, et al.
Published: (2014-01-01) -
2009 H1N1 Influenza
by: Seth J. Sullivan, MD; Robert M. Jacobson, MD; Walter R. Dowdle, PhD; and Gregory A. Poland
Published: (2011-04-01)